Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

COHANCE LIFESCIENCES LTD.

NSE : COHANCEBSE : 543064ISIN CODE : INE03QK01018Industry : Pharmaceuticals & DrugsHouse : Private

BSE1011.2088.1 (+9.54 %)

PREV CLOSE ( ) 923.10

OPEN PRICE ( ) 943.80

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 140049

TODAY'S LOW / HIGH ( )915.10 1038.00

52 WK LOW / HIGH ( )856.9 1359

NSE1012.9590.05 (+9.76 %)

PREV CLOSE( ) 922.90

OPEN PRICE ( ) 937.70

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 1012.95 (12565)

VOLUME 4938667

TODAY'S LOW / HIGH( ) 914.25 1038.90

52 WK LOW / HIGH ( )856.3 1360

Quarters

Select year

( in Million)

Particulars

Jun 2025

Mar 2025

Dec 2024

Sep 2024

Audited / UnAudited

UnAudited

Net Sales

5493.1

4020.2

3071.5

2577.2

Total Expenditure

4373

3284.6

1894.5

1537.1

PBIDT (Excl OI)

1120.1

735.6

1177

1040.1

Other Income

141.7

105.7

157.1

141.2

Operating Profit

1261.8

841.29

1334.1

1181.3

Interest

101.8

57.5

33.3

16.7

Exceptional Items

-81

PBDT

1079

783.79

1300.8

1164.6

Depreciation

451.4

267.8

203.5

169.6

Profit Before Tax

627.6

515.99

1097.3

995

Tax

163.6

128.7

264.4

175.2

Provisions and contingencies

Profit After Tax

464

387.29

832.9

819.8

Extraordinary Items

Prior Period Expenses

Other Adjustments

Net Profit

464

387.29

832.9

819.8

Minority Interest

24.8

32.8

-4.1

2.3

Shares of Associates

Other related items

Misc. Expenses Written off

Consolidated Net Profit

488.8

420.1

828.8

822.1

Equity Capital

382.6

254.6

Face Value (IN RS)

Reserves

Calculated EPS

1.27

1.65

3.25

3.22

Calculated EPS (Annualised)

5.11

6.60

13.02

12.91

No of Public Share Holdings

128488970

127025364

% of Public Share Holdings

33.59

49.9

PBIDTM% (Excl OI)

20.39

18.29

38.32

40.35

PBIDTM%

22.97

20.92

43.43

45.83

PBDTM%

19.64

19.49

42.35

45.18

PBTM%

11.42

12.83

35.72

38.60

PATM%

8.44

9.63

27.11

31.80

Notes

Risk Disclosures on Derivatives

Quarterly Results

COHANCE LIFESCIENCES LTD.